Literature DB >> 15855546

Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.

Jeff Powis1, Allison McGeer, Carla Duncan, Ryan Goren, Joyce C S de Azavedo, Darrin J Bast, Sylvia Pong-Porter, Tony Mazzulli, Karen Green, Barbara Willey, Donald E Low.   

Abstract

Fluoroquinolone susceptibility testing was performed on invasive group A streptococcus isolates from 1992-1993 and 2003 from Ontario, Canada. None were nonsusceptible to levofloxacin. Two of 153 (1.3%) from 1992-1993 and 7 of 160 (4.4%) from 2003 had a levofloxacin MIC of 2 mug/ml; all nine had parC mutations, and eight were serotype M6.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15855546      PMCID： PMC1087656          DOI： 10.1128/AAC.49.5.2130-2132.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

Authors:  Rodrigo Alonso; Marc Galimand; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.

Authors:  A L Barry; P C Fuchs; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

4.  Use of the serum-opacity reaction in the typing of group-A streptococci.

Authors:  W R Maxted; J P Widdowson; C A Fraser
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

5.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.

Authors:  D J Bast; D E Low; C L Duncan; L Kilburn; L A Mandell; R J Davidson; J C de Azavedo
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

7.  Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.

Authors:  S S Yan; M L Fox; S M Holland; F Stock; V J Gill; D P Fedorko
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Fluoroquinolone resistance in Streptococcus pyogenes.

Authors:  Sandra S Richter; Daniel J Diekema; Kris P Heilmann; Laurel S Almer; Virginia D Shortridge; Rod Zeitler; Robert K Flamm; Gary V Doern
Journal:  Clin Infect Dis       Date:  2003-01-14       Impact factor: 9.079

9.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

10.  New approaches for the laboratory recognition of M types of group A streptococci.

Authors:  J Rotta; R M Krause; R C Lancefield; W Everly; H Lackland
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307
View more
  10 in total

1.  Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates.

Authors:  M Montes; C Ardanuy; E Tamayo; A Domènech; J Liñares; E Pérez-Trallero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-15       Impact factor: 3.267

Review 2.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

3.  Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy.

Authors:  D Petrelli; M C Di Luca; M Prenna; P Bernaschi; A Repetto; L A Vitali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-05       Impact factor: 3.267

Review 4.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

5.  Antibiotic resistant beta-hemolytic streptococci.

Authors:  Charmaine A C Lloyd; Swarna E Jacob; Thangam Menon
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 1.967

6.  Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.

Authors:  G Soyletir; G Altinkanat; D Gur; B Altun; A Tunger; S Aydemir; C Kayacan; Z Aktas; M Gunaydin; A Karadag; H Gorur; I Morrissey; D Torumkuney
Journal:  J Antimicrob Chemother       Date:  2016-05       Impact factor: 5.790

7.  Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Celia L McNeilly; David J McMillan
Journal:  Front Microbiol       Date:  2014-12-15       Impact factor: 5.640

8.  Identification and Characterization of Fluoroquinolone Non-susceptible Streptococcus pyogenes Clones Harboring Tetracycline and Macrolide Resistance in Shanghai, China.

Authors:  Yinfang Shen; Jiehao Cai; Mark R Davies; Chi Zhang; Kun Gao; Dan Qiao; Haoqin Jiang; Weilei Yao; Yuefang Li; Mei Zeng; Mingliang Chen
Journal:  Front Microbiol       Date:  2018-03-23       Impact factor: 5.640

9.  Severe acute otitis media and mastoiditis caused by group A beta-hemolytic streptococcus.

Authors:  Juha T Laakso; Valtteri Rissanen; Eeva Ruotsalainen; Jarkko Korpi; Anu Laulajainen-Hongisto; Ville Sivonen; Saku T Sinkkonen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-16

10.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.